PhytoHealth Corporation

NT$10.60As of Sun 8 Nov 2026, 12:00 UTC
TWSE:4108Healthcare
Country Taiwan
PE (Fwd) •••
TSR 10Y CAGR (9.46%)
Div yield —
ROE (3.99%)
Drug Manufacturers (Specialty & Generic)
Beta (5Y) 0.37
PE TTM —
TSR TTM (24.01%)
Mkt cap NT$2.105B
ROIC (4.39%)
SE Grade™
Value
Quality
Moat
Consensus
Reference
NT$11
6.34%
(51.64%)
Hold 1|9|7|7|8
4Q25
1Q26
2Q26
3Q26
Earnings per shareNT$
0.14
0.15
0.16
0.18
25.78%
27.36%
32.38%
42.07%
RevenueNT$M
115.6
114.0
111.7
116.8
2.84%
(1.18%)
(1.44%)
5.98%
Peers (US$63.59M)
Cap (US$)
PE
59.32M
22.19x
Capital
TTM
5Y
10Y
Leveragex
5.121
(0.041)
(0.041)
EBIT/Intx
0.955
1.013
0.903
Own earn%
0.35
42.71
43.61
Sh yield%
54.81
45.07
44.84
Owners
Insiders/Inst%
0.74
54.78
Short interest%
1.41
SBC / revenue%
2.16
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
8
Op margin range%
28–34
$1 testx
—
Incr. ROIC%
21